Disease and Immune related mRNAs
-
R1025 EZ Cap™ Human PTEN mRNA2 CitationSummary: Human PTEN mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability. -
R1026 EZ Cap™ Human PTEN mRNA (ψUTP)Summary: Human PTEN mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1027 EZ Cap™ OVA mRNASummary: Ovalbumin mRNA with Cap 1 structure, providing higher transcription efficiency -
R1028 EZ Cap™ OVA mRNA (5-moUTP)1 CitationSummary: Ovalbumin mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
R1032 EZ Cap™ Mouse p53 mRNASummary: Mouse p53 mRNA with Cap 1 structure, providing high transcriptional efficiency -
R1033 EZ Cap™ Mouse p53 mRNA (ψUTP)Summary: Mouse p53 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1034 EZ Cap™ Mouse p53 mRNA (5-moUTP)Summary: Mouse p53 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1035 EZ Cap™ Fdx1 mRNASummary: Fdx1 mRNA with Cap 1 structure, providing high transcriptional efficiency -
R1036 EZ Cap™ Fdx1 mRNA (ψUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1037 EZ Cap™ Fdx1 mRNA (5-moUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

